FindTrial
Sign In

risk reducing salpingo-oophorectomy

5 trials

Sponsors

The Jikei university, school of medicine, Juntendo University, Kindai University Hospital, Fukushima Medical University, Shimane University Faculty of Medicine

Conditions

BRCA1, BRCA2,MLH1,MSH2,MSH6,PMS2,BRIP1,RAD51C or RAD51D mutation carriershereditary breast and ovarian cancerhereditary breast and ovarian cancer: HBOC

Unknown Phase

Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriers
RecruitingJPRN-UMIN000018302
The Jikei university, school of medicinehereditary breast and ovarian cancer
Start: 2015-08-01Target: 5Updated: 2026-06-29
Study of risk reducing bilateral salpingo-oophorectomy (RRSO) for japanese BRCA1/2 mutation carriers
Active, not recruitingJPRN-UMIN000020648
Juntendo Universityhereditary breast and ovarian cancer
Start: 2016-01-21Target: 30Updated: 2026-06-29
Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutation
Active, not recruitingJPRN-UMIN000023606
Kindai University Hospitalhereditary breast and ovarian cancer: HBOC
Start: 2016-08-12Target: 10Updated: 2026-06-29
Procedure of risk rducing surgery for hereditary gynecologic tumor
Active, not recruitingJPRN-UMIN000033751
Fukushima Medical UniversityBRCA1, BRCA2,MLH1,MSH2,MSH6,PMS2,BRIP1,RAD51C or RAD51D mutation carriers
Start: 2018-11-01Target: 30Updated: 2026-06-29
Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
RecruitingJPRN-UMIN000037086
Shimane University Faculty of Medicinehereditary breast and ovarian cancer
Start: 2017-05-01Target: 50Updated: 2026-06-29